ChartRow logo
Data provided bySource: Twelve Data
EHC
$137.88-2.98%
as of close, Nov 17, 2026
☾ AH $137.88 -2.98%
PeersENSGTHCUHSHCADVADGX
Share this page

EHC — Encompass Health Corporation price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in EHC be worth today? →
EHC returns: By year · By month · By week · Trailing

Price data

Price
$137.88
YTD price return
+29.90%
YTD total return
+30.86%
Market cap
13.5B
Enterprise value
17.4B
Shares outstanding
98.1M
52W low
$92.77
52W high
$143.90
From 52W high
-4.18%
From 52W low
+48.63%
52W range
88%$92.77–$144
Beta
0.77

Volume

Rel volume
0.83×
30D volume
1.1M
30D $ vol
144.3M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$1.2M
Insider net 1Y
−$47.8M

Form 4 transactions by trade date, as filed; latest on file 2026-08-31.

Fundamentals

Sales (ttm)
6.3B
Sales/share
$64.59
EPS (ttm)
$6.41
FCF (ttm)
457.2M
FCF/share
$4.66
Book value/share
$27.32
Net margin
10.17%
ROE
24.03%
ROA
8.52%
Debt / equity
0.95×
Current ratio
1.09

Growth (CAGR, ttm) · 10Y

Sales
+9.37%+10.54%+8.65%+5.85%
Net income
+19.13%+22.12%+9.65%+10.89%
FCF
+13.57%+21.50%+23.15%+0.52%
Shares
-2.48%-0.71%-0.28%+0.89%

Per-share growth (CAGR, ttm) · 10Y

EPS
+21.11%+22.33%+9.56%+10.37%
Sales/share
+12.15%+11.33%+8.95%+4.80%
FCF/share
+16.46%+22.40%+23.50%-0.37%
Book value/share
+15.83%+20.62%+8.09%+12.95%
Dividend/share
+11.44%+9.14%-6.98%-1.74%
Price
+23.12%+28.93%+22.21%+15.66%
Total return
+24.04%+29.85%+23.40%+17.25%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
21.5×
Fwd P/E
20.5×
P/S (ttm)
2.1×
P/B (mrq)
5.0×
P/FCF (ttm)
29.6×
EV/EBITDA (fy)
12.9×
EV/Sales (ttm)
2.7×
FCF yield (ttm)
3.38%
Dividend yield (fwd)Div yield
0.61%
Dividend yield (ttm)
0.57%
Dividend/share (fwd)
$0.84
Buyback yield (realized, 1y)
2.48%
Shareholder yield (realized, 1y)
3.08%
Buyback yield (cash, ttm)
2.07%
Shareholder yield (cash, ttm)
2.64%

Vs own 10Y history

P/E
70th
P/S
96th
P/B
93rd
P/FCF
78th

Bar = where today’s multiple sits in EHC’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-17#

Data provided bySource: Twelve Data
1D
-2.98%
5D
-3.25%
1M
+7.83%
3M
+13.03%
YTD
+29.90%
1Y
+23.11%
5Y
+172.55%
1D
-2.98%
5D
-3.25%
1M
+7.83%
3M
+13.22%
YTD
+30.86%
1Y
+24.02%
5Y
+186.10%

Fundamentals#

Revenue

5Y CAGR +10.7%5Y CAGR +10.7%YoY +8.9%
$6.3B TTM$1.6B Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +14.8%10Y CAGR +12.0%YoY +18.5%
$644.4M TTM$149.9M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +14.2%10Y CAGR +11.2%YoY +21.0%
$6.41 TTM$1.50 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +7.7%10Y CAGR +2.4%YoY +52.3%
$457.2M TTM$127.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $1.3B, capex −$846.5M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $362M, capex −$234.5M

Shares (diluted)

5Y +2.4%10Y +1.2%YoY −2.5%
100.5M TTM99.7M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR −8.5%10Y CAGR −2.0%YoY +10.5%
$0.78 TTM$0.21 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full EHC financials →

Encompass Health Corporation is a post-acute healthcare company focused on inpatient rehabilitation hospitals. The company provides specialized, facility-based care for patients recovering from strokes, neurological disorders, brain and spinal cord injuries, cardiac and pulmonary conditions, complex orthopedic cases, amputations, and other serious illnesses or injuries. Its services combine medical, nursing, therapy, and ancillary support to help patients regain functional ability, independence, and quality of life. Encompass Health operates a national network of rehabilitation hospitals across the United States and Puerto Rico, making it a significant provider in the inpatient rehabilitation market. Based in Birmingham, Alabama, Encompass Health plays a central role in delivering coordinated recovery care for patients who need intensive, medically supervised rehabilitation after hospitalization.

Birmingham, AL·29,699 employees·Medical Care Facilities·encompasshealth.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding EHC#

19 of the 193 ETFs ChartRow carries live hold EHC. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
IJHiShares Core S&P Mid-Cap ETF0.3%
MDYSPDR S&P MidCap 400 ETF Trust0.3%
VBRVanguard Small-Cap Value ETF0.2%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.1%
VXFVanguard Extended Market ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+12.61%-1.13%
JNJJohnson & Johnson+9.05%-1.36%
ABBVAbbVie Inc.+2.59%-0.59%
MRKMerck & Co. Inc.-1.77%-0.75%
UNHUnitedHealth Group Incorporated Common Stock (DE)-2.93%-5.42%
NVSNovartis AG+5.65%-0.67%
TMOThermo Fisher Scientific Inc.-0.47%-0.66%
AMGNAmgen Inc.+5.88%-0.95%